Portola Pharmaceuticals, Inc. Long-Term Debt
Portola Pharmaceuticals, Inc. had Long-Term Debt of $118.10 million as of 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2020-02-28
- 2019-12-31: Long-term Debt, Excluding Current Maturities $118.10M.
- 2019-09-30: Long-term Debt, Excluding Current Maturities $57.27M.
- 2019-06-30: Long-term Debt, Excluding Current Maturities $57.06M.
- 2019-03-31: Long-term Debt, Excluding Current Maturities $56.84M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2019-12-31 | $118.10M 10-K · filed 2020-02-28 | |
| 2019-09-30 | $57.27M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $57.06M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $56.84M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $0.00 10-K · filed 2020-02-28 | $155.26M 10-K · filed 2019-03-01 |
| 2018-09-30 | $152.68M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $150.30M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $56.03M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $54.25M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $52.39M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $50.12M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $47.80M 10-Q · filed 2017-05-09 |